C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Increases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.2% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,367 shares of the healthcare conglomerate’s stock after acquiring an additional 238 shares during the period. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors’ holdings in UnitedHealth Group were worth $1,384,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Macroview Investment Management LLC raised its holdings in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares in the last quarter. Delos Wealth Advisors LLC lifted its position in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 53 shares during the last quarter. True Wealth Design LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth about $31,000. Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at about $31,000. Finally, Global Wealth Strategies & Associates grew its stake in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock opened at $591.22 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The company has a market cap of $545.94 billion, a price-to-earnings ratio of 36.14, a PEG ratio of 1.65 and a beta of 0.58. The firm has a 50 day moving average of $582.68 and a 200-day moving average of $529.13. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the previous year, the company posted $6.14 EPS. The business’s revenue was up 6.4% on a year-over-year basis. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.42%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is 51.34%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on UNH. Truist Financial increased their price objective on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, September 25th. Argus increased their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. HSBC boosted their price target on UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. Finally, Morgan Stanley lifted their target price on UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.